February 21, 2019 — At the recent Healthcare Information and Management Systems Society (HIMSS) annual conference, AT&T’s healthcare team demonstrated the key role connectivity and the internet of medical things (IoMT) plays throughout the continuum of care. This concept was highlighted by a demonstration of the Bodyport remote monitoring solution.
The device, being developed by the San Francisco-based company Bodyport, can help detect early signs of cardiovascular disease. By stepping on the Bodyport scale, the device’s sensor technology captures electrical and mechanical heart function, data that is typically only available through in-clinic measures such as electrocardiogram (ECG) and echocardiography. The AT&T LTE-M cellular network enables the transmission of multiple biomarkers of cardiovascular function to a remote care team. This allows the clinician to determine in near real-time patient risk and status.
Bodyport is currently performing clinical trials at leading hospitals. They are studying patients with cardiometabolic risk factors like high blood pressure and diabetes. They are also monitoring heart failure patients to help clinicians identify those at highest risk of readmissions.
For more information: www.business.att.com, www.bodyport.com
August 15, 2024 
